Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.2, indicating a deployment of a newer site version; this update is a system-level change rather than a content modification.
    Difference
    0.1%
    Check dated 2026-06-28T08:20:22.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    No additions or deletions are present, so the page content remains unchanged. The study details and related information are shown as before.
    Difference
    0.1%
    Check dated 2026-06-21T04:47:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants', indicating recruitment is closed, and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note; the older 'Intervention / Treatment' header formatting and the previous revision note (v3.5.5) were removed.
    Difference
    0.4%
    Check dated 2026-06-14T03:27:08.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.4 to v3.5.5, indicating a site version release. This change is a backend/UI update and does not modify the study details or data presented on the page.
    Difference
    0.1%
    Check dated 2026-06-06T23:41:46.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    No text changes were provided for this page. There are no updates to summarize.
    Difference
    0.1%
    Check dated 2026-05-30T19:41:14.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    There are no changes detected in the provided data. The study details page content remains unchanged, reflecting existing information about the Derazantinib trial for FGFR2-altered intrahepatic cholangiocarcinoma.
    Difference
    0.1%
    Check dated 2026-05-23T13:37:52.000Z thumbnail image

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.